IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Tue, 12 Aug · 12:06 IST

IPCA Laboratories Limited has submitted the Exchange a copy of Srutinizers report of Annual General Meeting held on August 11, 2025 along with voting results

Board & Shareholder Meetings View source PDF

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

IPCA Laboratories Limited held its 75th AGM on August 11, 2025 via video conferencing, where all 8 resolutions were passed by the required majority. Out of 85,632 shareholders on record date, about 87.97% of outstanding shares (22.31 crore shares) were polled through remote e-voting. Resolutions included adoption of audited financial statements (standalone and consolidated) for FY25, confirmation of dividend on equity shares, re-appointment of directors Mr. Prashant Godha and Mr. Premchand Godha, appointment of Parikh & Associates as Secretarial Auditors for 5 years, ratification of Cost Auditors' remuneration, and alterations to the Memorandum and Articles of Association. While 7 of 8 resolutions passed with over 98% support, the re-appointment of Mr. Prashant Godha saw notable dissent of 8.50% (1.89 crore shares), driven mainly by 17.41% opposition from institutional holders, making it the most contested resolution.

Likely market impact

All agenda items, including the FY25 dividend, were cleared by shareholders, confirming continued capital returns and stable governance. The unusual institutional dissent on Mr. Prashant Godha's re-appointment (though the resolution still passed with 91.5%) is worth monitoring but unlikely to move the stock, as overall voting turnout and outcomes reflect strong shareholder confidence.